Tenax Therapeutics, Inc. · NASDAQ:TENX

BVF PARTNERS L P/IL reported a 9.99% stake in Tenax Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

BVF PARTNERS L P/IL reported a 9.99% stake in Tenax Therapeutics, Inc., 1,908,722 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
9.99%
Shares
1,908,722
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P9.20%1,754,719
BVF I GP LLC9.20%1,754,719
BIOTECHNOLOGY VALUE FUND II LP0.90%149,536
BVF II GP LLC0.90%149,536
Biotechnology Value Trading Fund OS LP0%0
BVF Partners OS Ltd.0%0
BVF GP HOLDINGS LLC9.97%1,904,255
BVF PARTNERS L P/IL9.99%1,908,722
BVF INC/IL9.99%1,908,722
LAMPERT MARK N9.99%1,908,722

Source

View original at SEC

Related